Betaglycan Inhibits TGF-β Signaling by Preventing Type I-Type II Receptor Complex Formation
Open Access
- 1 January 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (1), 823-829
- https://doi.org/10.1074/jbc.m105110200
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Specificity, diversity, and regulation in TGF‐β superfamily signalingThe FASEB Journal, 1999
- Requirement of Type III TGF-β Receptor for Endocardial Cell Transformation in the HeartScience, 1999
- TGF-β SIGNAL TRANSDUCTIONAnnual Review of Biochemistry, 1998
- Betaglycan has multiple binding sites for transforming growth factor-β 1Biochemical Journal, 1996
- Expression of Transforming Growth Factor Type III Receptor in Vascular Endothelial Cells Increases Their Responsiveness to Transforming Growth Factor β2Journal of Biological Chemistry, 1995
- Betaglycan presents ligand to the TGFβ signaling receptorCell, 1993
- Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)Growth Factors, 1993
- Expression cloning and characterization of the TGF-β type III receptorCell, 1991
- Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor systemCell, 1991
- Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta.The Journal of cell biology, 1989